Grifols s a

Major-Pharmaceuticals

GRFS


Avinguda de la Generalitat, 152-158
Barcelona , 08174

Executive/
Director

Price

  • Last Close
  • $ 7.72
    $ +0.17 2.25 %
    Jan 3, 2025
  • 52-Week High/Low
  • $11.56 - $5.47
  • YTD
  • 0%

  • Trading Volume
  • 22,412
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 17.4% -7.5% 9.5% -5% -5.6% 4% -13.3% -42.2% 3.8% -
Q2 12.8% 5.6% 4.2% 4% -0.3% 1.7% 24.3% -5.3% - -
Q3 3.6% -0.1% -3.6% 8% -15.4% -48.2% -0.2% 21.9% - -
Q4 6.8% -13.3% 14.3% 8.7% -23.5% 38% 28.3% 2.1% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 3.8% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    1%45%-18%26%-20%-39%-24%36%-36%4%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.26 0.29 - 0.24 - - -
Q2 0.27 0.31 0.33 - - - 0.09
Q3 0.29 - 0.28 - - - -
Q4 0.28 1.03 1.02 1.03 0.33 - -
A 1.1 1.6 1.6 1.3 0.3 0 0.09

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2021
Q1 0.37
Q2 -
Q3 -
Q4 -
A 0.37
Mar
Jun
Sep
Dec

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.2 1.3 1.5 1.2 1.3
Fixed Asset Turnover 1 0.9 1.1 1.6 2
Total Asset Turnover 0.3 0.3 0.4 0.3 0.4
Leverage
Interest Coverage 1.4 1.5 2.6 2.2 2.5
Debt Ratio 2.1 1.4 2.1 1.3 1.8
Debt – Equity Ratio 1.2 1.1 1 1 1.3
Equity multiplier 0.7 0.8 0.8 0.5 0.5